Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex

References

• Lin X, Heitman J. The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol 2006; 60: 69–105.
   PubMed Web of Science ®Google Scholar
• Meyer W, Castañeda A, Jackson S, . Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 2003; 9: 189–195.
   PubMed Web of Science ®Google Scholar
• Boekhout T, Theelen B, Diaz M, . Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 2001; 147: 891–907.
   PubMed Web of Science ®Google Scholar
• Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol 2001; 39: 155–168.
   PubMed Web of Science ®Google Scholar
• Kidd SE, Hagen F, Tscharke RL, . A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101: 17258–17263.
   PubMed Web of Science ®Google Scholar
• Trilles L, Fernández-Torres B, Lazéra MS, . In vitro antifungal susceptibility of Cryptococcus gattii. J Clin Microbiol 2004; 42: 4815–4817.
   PubMed Web of Science ®Google Scholar
• Khan ZU, Randhawa HS, Kowshik T, . Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India. J Antimicrob Chemother 2007; 60: 312–316.
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Abdul M, Arpin M, . Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother 2006; 50: 2464–2470.
   PubMed Web of Science ®Google Scholar
• Tay ST, Tanty Haryanty T, Ng KP, . In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs. Mycoses 2006; 49: 324–330.
   PubMed Web of Science ®Google Scholar
• Thompson GR 3rd, Wiederhold NP, Fothergill AW, . Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother 2009; 53: 309–311.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
   Google Scholar
• Meyer W, Aanensen DM, Boekhout T, . Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 2009; 47: 561–570.
   PubMed Web of Science ®Google Scholar
• Varma A, Kwon-Chung KJ. Heteroresistance of Cryptococcus gattii to fluconazole. Antimicrob Agents Chemother 2010; 54: 2303–2311.
   PubMed Web of Science ®Google Scholar
• Chong HS, Dagg R, Malik R, . In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol 2010; 48: 4115–4120.
   PubMed Web of Science ®Google Scholar
• Hagen F, Illnait-Zaragozi MT, Bartlett KH, . In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 2010; 54: 5139–5145.
   PubMed Web of Science ®Google Scholar
• Iqbal N, DeBess EE, Wohrle R, . Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol 2010; 48: 539–544.
   PubMed Web of Science ®Google Scholar
• Sionov E, Lee H, Chang YC, . Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog 2010; 6: e1000848.
   PubMed Web of Science ®Google Scholar
• Meyer W, Trilles L. Genotyping of the Cryptococcus neoformans/ C. gattii species complex. Aust Biochem 2010; 41: 11–15.
   Google Scholar
• Perfect JR, Dismukes WE, Dromer F, . Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 291–322.
   PubMed Web of Science ®Google Scholar
• Jarvis JN, Meintjes G, Williams Z, . Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis. S Afr Med J 2010; 100: 378–382.
   PubMed Web of Science ®Google Scholar
• Diz Dios P, Ocampo A, Miralles C, . Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 437–441.
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Randhawa HS, Sundar G, . In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var grubii and Cryptococcus gattii serotype B from north-western India. J Med Microbiol 2011; 60: 961–967.
   PubMed Web of Science ®Google Scholar